Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8557987rdf:typepubmed:Citationlld:pubmed
pubmed-article:8557987lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:8557987lifeskim:mentionsumls-concept:C0025914lld:lifeskim
pubmed-article:8557987lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:8557987lifeskim:mentionsumls-concept:C0039195lld:lifeskim
pubmed-article:8557987lifeskim:mentionsumls-concept:C0205169lld:lifeskim
pubmed-article:8557987lifeskim:mentionsumls-concept:C0872192lld:lifeskim
pubmed-article:8557987lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:8557987lifeskim:mentionsumls-concept:C0079411lld:lifeskim
pubmed-article:8557987lifeskim:mentionsumls-concept:C0205225lld:lifeskim
pubmed-article:8557987pubmed:issue3lld:pubmed
pubmed-article:8557987pubmed:dateCreated1996-2-27lld:pubmed
pubmed-article:8557987pubmed:abstractTextThis study investigated the generation of primary tumor-specific CTL activity in vitro to several mouse tumors. We report that the development of optimal primary tumor-specific CTL to the P815 mastocytoma, the EL4 thymoma, and the Lewis lung carcinoma is dependent on tumor Ags, on enhancement of T cell costimulation by B7.1, and on exogenous T helper activity in the form of IL-2 and IL-4. A relatively low concentration of IL-2 and IL-4 was required to limit the induction of lymphokine-activated killer cells. In the case of P815, the CTL were directed toward molecularly defined tumor rejection Ags. These primary cultures yielded long term T cell lines that were heterogeneous in fine tumor Ag specificity and in cytokine production.lld:pubmed
pubmed-article:8557987pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8557987pubmed:languageenglld:pubmed
pubmed-article:8557987pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8557987pubmed:citationSubsetAIMlld:pubmed
pubmed-article:8557987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8557987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8557987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8557987pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8557987pubmed:statusMEDLINElld:pubmed
pubmed-article:8557987pubmed:monthFeblld:pubmed
pubmed-article:8557987pubmed:issn0022-1767lld:pubmed
pubmed-article:8557987pubmed:authorpubmed-author:LinKKlld:pubmed
pubmed-article:8557987pubmed:authorpubmed-author:MalekT RTRlld:pubmed
pubmed-article:8557987pubmed:authorpubmed-author:AllisonJ PJPlld:pubmed
pubmed-article:8557987pubmed:authorpubmed-author:PodackE RERlld:pubmed
pubmed-article:8557987pubmed:issnTypePrintlld:pubmed
pubmed-article:8557987pubmed:day1lld:pubmed
pubmed-article:8557987pubmed:volume156lld:pubmed
pubmed-article:8557987pubmed:ownerNLMlld:pubmed
pubmed-article:8557987pubmed:authorsCompleteYlld:pubmed
pubmed-article:8557987pubmed:pagination1117-25lld:pubmed
pubmed-article:8557987pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:8557987pubmed:meshHeadingpubmed-meshheading:8557987-...lld:pubmed
pubmed-article:8557987pubmed:meshHeadingpubmed-meshheading:8557987-...lld:pubmed
pubmed-article:8557987pubmed:meshHeadingpubmed-meshheading:8557987-...lld:pubmed
pubmed-article:8557987pubmed:meshHeadingpubmed-meshheading:8557987-...lld:pubmed
pubmed-article:8557987pubmed:meshHeadingpubmed-meshheading:8557987-...lld:pubmed
pubmed-article:8557987pubmed:meshHeadingpubmed-meshheading:8557987-...lld:pubmed
pubmed-article:8557987pubmed:meshHeadingpubmed-meshheading:8557987-...lld:pubmed
pubmed-article:8557987pubmed:meshHeadingpubmed-meshheading:8557987-...lld:pubmed
pubmed-article:8557987pubmed:meshHeadingpubmed-meshheading:8557987-...lld:pubmed
pubmed-article:8557987pubmed:meshHeadingpubmed-meshheading:8557987-...lld:pubmed
pubmed-article:8557987pubmed:meshHeadingpubmed-meshheading:8557987-...lld:pubmed
pubmed-article:8557987pubmed:meshHeadingpubmed-meshheading:8557987-...lld:pubmed
pubmed-article:8557987pubmed:meshHeadingpubmed-meshheading:8557987-...lld:pubmed
pubmed-article:8557987pubmed:meshHeadingpubmed-meshheading:8557987-...lld:pubmed
pubmed-article:8557987pubmed:meshHeadingpubmed-meshheading:8557987-...lld:pubmed
pubmed-article:8557987pubmed:year1996lld:pubmed
pubmed-article:8557987pubmed:articleTitleGeneration of primary tumor-specific CTL in vitro to immunogenic and poorly immunogenic mouse tumors.lld:pubmed
pubmed-article:8557987pubmed:affiliationDepartment of Microbiology and Immunology, University of Miami School of Medicine, FL 33136, USA.lld:pubmed
pubmed-article:8557987pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8557987pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8557987lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8557987lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8557987lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8557987lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8557987lld:pubmed